347 related articles for article (PubMed ID: 27552533)
21. Brain-Derived Neurotrophic Factor in the Cerebrospinal Fluid Increases During Electroconvulsive Therapy in Patients With Depression: A Preliminary Report.
Mindt S; Neumaier M; Hellweg R; Sartorius A; Kranaster L
J ECT; 2020 Sep; 36(3):193-197. PubMed ID: 32118691
[TBL] [Abstract][Full Text] [Related]
22. BDNF serum levels and promoter methylation of BDNF exon I, IV and VI in depressed patients receiving electroconvulsive therapy.
Kleimann A; Kotsiari A; Sperling W; Gröschl M; Heberlein A; Kahl KG; Hillemacher T; Bleich S; Kornhuber J; Frieling H
J Neural Transm (Vienna); 2015 Jun; 122(6):925-8. PubMed ID: 25387785
[TBL] [Abstract][Full Text] [Related]
23. Brain-derived neurotrophic factor blood levels after electroconvulsive therapy in patients with mental disorders: A systematic review and meta-analysis.
Wang Z; Zou Z; Xiao J; Min W; Nan LP; Yuan C; Yuan L; Yang C; Huang R; He Y
Gen Hosp Psychiatry; 2023; 83():86-92. PubMed ID: 37148598
[TBL] [Abstract][Full Text] [Related]
24. Effects of electroconvulsive therapy on serum levels of brain-derived neurotrophic factor and nerve growth factor in treatment resistant major depression.
Bilgen AE; Bozkurt Zincir S; Zincir S; Ozdemir B; Ak M; Aydemir E; Sener I
Brain Res Bull; 2014 May; 104():82-7. PubMed ID: 24747833
[TBL] [Abstract][Full Text] [Related]
25. ECT seizure quality and serum BDNF, revisited.
Sartorius A; Bumb JM; Aksay SS; Gass P; Hellweg R; Kranaster L
Eur Arch Psychiatry Clin Neurosci; 2015 Jun; 265(4):359-60. PubMed ID: 25651974
[No Abstract] [Full Text] [Related]
26. Plasma Brain-Derived Neurotrophic Factor in treatment-resistant depressed patients receiving electroconvulsive therapy.
Piccinni A; Del Debbio A; Medda P; Bianchi C; Roncaglia I; Veltri A; Zanello S; Massimetti E; Origlia N; Domenici L; Marazziti D; Dell'Osso L
Eur Neuropsychopharmacol; 2009 May; 19(5):349-55. PubMed ID: 19223156
[TBL] [Abstract][Full Text] [Related]
27. Polymorphism of the brain-derived neurotrophic factor and dynamics of the seizure threshold of electroconvulsive therapy.
Stephani C; Shoukier M; Ahmed R; Wolff-Menzler C
Eur Arch Psychiatry Clin Neurosci; 2017 Dec; 267(8):787-794. PubMed ID: 27787610
[TBL] [Abstract][Full Text] [Related]
28. Structural-functional brain changes in depressed patients during and after electroconvulsive therapy.
Yrondi A; Péran P; Sauvaget A; Schmitt L; Arbus C
Acta Neuropsychiatr; 2018 Feb; 30(1):17-28. PubMed ID: 27876102
[TBL] [Abstract][Full Text] [Related]
29. Does Physical Exercise Increase Brain-Derived Neurotrophic Factor in Major Depressive Disorder? A Meta-Analysis.
Kurebayashi Y; Otaki J
Psychiatr Danub; 2018 Jun; 30(2):129-135. PubMed ID: 29930221
[TBL] [Abstract][Full Text] [Related]
30. Effects of COMT, DRD2, BDNF, and APOE Genotypic Variation on Treatment Efficacy and Cognitive Side Effects of Electroconvulsive Therapy.
Bousman CA; Katalinic N; Martin DM; Smith DJ; Ingram A; Dowling N; Ng C; Loo CK
J ECT; 2015 Jun; 31(2):129-35. PubMed ID: 25148110
[TBL] [Abstract][Full Text] [Related]
31. Electroconvulsive therapy exerts mainly acute molecular changes in serum of major depressive disorder patients.
Stelzhammer V; Guest PC; Rothermundt M; Sondermann C; Michael N; Schwarz E; Rahmoune H; Bahn S
Eur Neuropsychopharmacol; 2013 Oct; 23(10):1199-207. PubMed ID: 23183131
[TBL] [Abstract][Full Text] [Related]
32. Focus on ECT seizure quality: serum BDNF as a peripheral biomarker in depressed patients.
Bumb JM; Aksay SS; Janke C; Kranaster L; Geisel O; Gass P; Hellweg R; Sartorius A
Eur Arch Psychiatry Clin Neurosci; 2015 Apr; 265(3):227-32. PubMed ID: 25231834
[TBL] [Abstract][Full Text] [Related]
33. EFFICACY AND LONG-TERM CLINICAL OUTCOME OF COMORBID POSTTRAUMATIC STRESS DISORDER AND MAJOR DEPRESSIVE DISORDER AFTER ELECTROCONVULSIVE THERAPY.
Ahmadi N; Moss L; Simon E; Nemeroff CB; Atre-Vaidya N
Depress Anxiety; 2016 Jul; 33(7):640-7. PubMed ID: 26555786
[TBL] [Abstract][Full Text] [Related]
34. Effect of electroconvulsive therapy on gray matter volume in major depressive disorder.
Ota M; Noda T; Sato N; Okazaki M; Ishikawa M; Hattori K; Hori H; Sasayama D; Teraishi T; Sone D; Kunugi H
J Affect Disord; 2015 Nov; 186():186-91. PubMed ID: 26247910
[TBL] [Abstract][Full Text] [Related]
35. Electroconvulsive stimulation alters levels of BDNF-associated microRNAs.
Ryan KM; O'Donovan SM; McLoughlin DM
Neurosci Lett; 2013 Aug; 549():125-9. PubMed ID: 23721784
[TBL] [Abstract][Full Text] [Related]
36. [ECT: from neuronal plasticity to mechanisms underlying antidepressant medication effect].
Holtzmann J; Polosan M; Baro P; Bougerol T
Encephale; 2007 Sep; 33(4 Pt 1):572-8. PubMed ID: 18033145
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depressed patients: a pilot study.
Okamoto T; Yoshimura R; Ikenouchi-Sugita A; Hori H; Umene-Nakano W; Inoue Y; Ueda N; Nakamura J
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1185-90. PubMed ID: 18403081
[TBL] [Abstract][Full Text] [Related]
38. Adjunctive ketamine and electroconvulsive therapy for major depressive disorder: A meta-analysis of randomized controlled trials.
Zheng W; Li XH; Zhu XM; Cai DB; Yang XH; Ungvari GS; Ng CH; Ning YP; Hu YD; He SH; Wang G; Xiang YT
J Affect Disord; 2019 May; 250():123-131. PubMed ID: 30852364
[TBL] [Abstract][Full Text] [Related]
39. Magnetic Seizure Therapy for Unipolar and Bipolar Depression: A Systematic Review.
Cretaz E; Brunoni AR; Lafer B
Neural Plast; 2015; 2015():521398. PubMed ID: 26075100
[TBL] [Abstract][Full Text] [Related]
40. Retrospective evaluation of the dexamethasone suppression test as a predictor of response to electroconvulsive therapy in patients with comorbid major depressive disorder and posttraumatic stress disorder.
Watts BV; Groft A
J ECT; 2010 Sep; 26(3):213-7. PubMed ID: 20386115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
